Facility (object) – Talk Bio

Actionable Insights Powered by AI

Ypsomed Invests $248 Million to Establish First U.S. Manufacturing Site in North Carolina

2 weeks ago talkbio0Tagged CHF, expansion, Facility (object), global growth strategy, Holly Springs, Manufacturing, medical technology, North Carolina, self-injection systems, Surgical construction, United States, Ypsomed

Ypsomed; manufacturing expansion; U.S. facility; Holly Springs; North Carolina; CHF 200 million; self-injection systems; job creation; global growth strategy; medical technology

AbbVie Invests $195 Million in New North Chicago API Manufacturing Site

2 months ago talkbio0Tagged AbbVie, alpha 1-antitrypsin, domestic production, expansion, Facility (object), Illinois (geographic location), Investments, Manufacturing, North Chicago, pharmaceutical manufacturing

AbbVie; North Chicago; API manufacturing; $195 million investment; facility expansion; pharmaceutical manufacturing; Illinois; domestic production

FDA Launches PreCheck Program to Accelerate Domestic Drug Manufacturing

3 months ago talkbio0Tagged alpha 1-antitrypsin, Construction worker, domestic drug manufacturing, Facility (object), National Security, Pharmaceutical Supply Chain, PreCheck, regulatory streamlining, Trump administration, United States Food and Drug Administration

FDA PreCheck; domestic drug manufacturing; pharmaceutical supply chain; API; regulatory streamlining; facility construction; national security; Trump administration

Gilead Lays Off 36 Employees After Cancelling Oceanside, California Expansion

4 months ago talkbio0Tagged Biological Factors, biotech industry, California, co-location, expansion, Facility (object), Foster City, Gilead Sciences, layoffs, Oceanside

Gilead Sciences; layoffs; Oceanside; California; biologics; facility expansion; job cuts; biotech industry; co-location; Foster City

Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures

6 months ago talkbio0Tagged Biosciences, Biotech Layoffs, Collaboration termination, Facility (object), IgM antibodies, Immunoglobulin M, Immunology, Inflammation, Neoplasms, Reparative closure, sanofi

Sanofi, IGM Biosciences, collaboration termination, biotech layoffs, facility closures, IgM antibodies, immunology, inflammation, oncology

J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms

8 months ago talkbio0Tagged Carvykti, competition, Facility (object), Investments, J&J, Johnson and Johnson, Multiple Myeloma, production

Carvykti, Johnson and Johnson, Investments, J&J, Facility (object), Multiple Myeloma, production, competition

Corrected: Merck opens billion-dollar US facility to make Gardasil

8 months ago talkbio0Tagged Facility (object), Gardasil, Merck, Merck 's, United States, Vaccines

Merck, Gardasil, Facility (object), Vaccines, Merck ‘s, United States

Merck opens $1B Gardasil manufacturing facility in North Carolina

8 months ago talkbio0Tagged Durham, Facility (object), Manufacture, Merck, North Carolina

Merck, Facility (object), Manufacture, Durham, North Carolina

Charles River Laboratories Closing Durham Facility, Laying Off 31 Employees

9 months ago talkbio0Tagged Charles, Contract Research Organization, Durham, Facility (object), North Carolina, Pharmaceutical Research, Reparative closure, restructuring, River Laboratories

Charles River Laboratories, Durham, North Carolina, facility closure, layoffs, pharmaceutical research, contract research organization, restructuring

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

10 months ago talkbio0Tagged asset, Biological Factors, BIOSECURE, Dundalk, Facility (object), Ireland, Merck, regulatory, Sales - occupational activity, strategic shift, Vaccines, WuXi

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act